Globalizing pharmaceutical trials
نویسندگان
چکیده
منابع مشابه
Clinical trials and the pharmaceutical industry.
Authorization to market a drug is conditioned on submitting the results of clinical trials, proving that the product meets national and international standards and that it can be used to benefit human health. Who presents the proof? The manufacturer. Who authorizes use of the drug? The national regulatory agencies. Clinical trials are the epidemiological approach that provides the best evidence...
متن کامل[Clinical trials, pharmaceutical companies and clinical practice].
INTRODUCCIÓN Los médicos y la industria farmacéutica comparten el objetivo del progreso en el conocimiento científico; sin embargo, el principal interés del médico es proporcionar a sus pacientes el mejor tratamiento posible, mientras que el principal interés de la industria es vender su producto. La industria farmacéutica colabora en el desarrollo de importantes avances en medicina y tecnologí...
متن کاملPotential bias in ophthalmic pharmaceutical clinical trials
To make clinicians aware of potential sources of error in ophthalmic pharmaceutical clinical trials that can lead to erroneous interpretation of results, a critical review of the study design of various pharmaceutical ophthalmic clinical trials was completed. Discrepancies as a result of study shortcomings may explain observed differences between reported ophthalmic trial data and observed clin...
متن کاملGlobalizing Domain - Specific Languages
This report documents the program and the outcomes of the Dagstuhl Seminar 14412 “Globalizing Domain-Specific Languages” held in October 2014. Complex, data-intensive, cyber-physical, cloud-based etc. systems need effective modeling techniques, preferably based on DSLs to describe aspects and views. Models written in heterogeneous languages however need to be semantically compatible and their s...
متن کاملGlobalizing Constraint Models
We present a method that, given a constraint model, suggests global constraints to replace parts of it. This helps non-expert users to write higher-level models that are easier to reason about and may result in better solving performance. Our method exploits the structure of the model by considering combinations of the constraints, collections of variables, parameters and loops already present ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Medicine
سال: 2010
ISSN: 1078-8956,1546-170X
DOI: 10.1038/nm0310-262